Pura Vida Investments, LLC Biomarin Pharmaceutical Inc Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $12.5 Million - $15.2 Million	-175,356 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $382,244 - $476,982	5,146 Added 3.02%	175,356 $13.5 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $12.2 Million - $15.6 Million	170,210 New	170,210 $15 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $726,100 - $902,000	-10,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $718,700 - $1.31 Million	10,000 New	10,000 $761,000
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $3.32 Million - $4.33 Million	-43,700 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $3.53 Million - $4.16 Million	43,700	43,700 $0

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.